124 related articles for article (PubMed ID: 15342384)
1. Mek1 alters epidermal growth and differentiation.
Scholl FA; Dumesic PA; Khavari PA
Cancer Res; 2004 Sep; 64(17):6035-40. PubMed ID: 15342384
[TBL] [Abstract][Full Text] [Related]
2. Properties of MEKs, the kinases that phosphorylate and activate the extracellular signal-regulated kinases.
Zheng CF; Guan KL
J Biol Chem; 1993 Nov; 268(32):23933-9. PubMed ID: 8226933
[TBL] [Abstract][Full Text] [Related]
3. Loss of active MEK1-ERK1/2 restores epithelial phenotype and morphogenesis in transdifferentiated MDCK cells.
Schramek H; Feifel E; Marschitz I; Golochtchapova N; Gstraunthaler G; Montesano R
Am J Physiol Cell Physiol; 2003 Sep; 285(3):C652-61. PubMed ID: 12900389
[TBL] [Abstract][Full Text] [Related]
4. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.
Bardwell AJ; Abdollahi M; Bardwell L
Biochem J; 2003 Mar; 370(Pt 3):1077-85. PubMed ID: 12529172
[TBL] [Abstract][Full Text] [Related]
5. Mitogen-activated protein kinase feedback phosphorylation regulates MEK1 complex formation and activation during cellular adhesion.
Eblen ST; Slack-Davis JK; Tarcsafalvi A; Parsons JT; Weber MJ; Catling AD
Mol Cell Biol; 2004 Mar; 24(6):2308-17. PubMed ID: 14993270
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of mitogen-activated protein/ERK kinase (MEK)1 and MEK2 and activation by a Ras-independent mechanism.
Xu S; Khoo S; Dang A; Witt S; Do V; Zhen E; Schaefer EM; Cobb MH
Mol Endocrinol; 1997 Oct; 11(11):1618-25. PubMed ID: 9328344
[TBL] [Abstract][Full Text] [Related]
7. cAMP inhibits the proliferation of retinal pigmented epithelial cells through the inhibition of ERK1/2 in a PKA-independent manner.
Hecquet C; Lefevre G; Valtink M; Engelmann K; Mascarelli F
Oncogene; 2002 Sep; 21(39):6101-12. PubMed ID: 12203122
[TBL] [Abstract][Full Text] [Related]
8. Selective role for Mek1 but not Mek2 in the induction of epidermal neoplasia.
Scholl FA; Dumesic PA; Barragan DI; Harada K; Charron J; Khavari PA
Cancer Res; 2009 May; 69(9):3772-8. PubMed ID: 19383924
[TBL] [Abstract][Full Text] [Related]
9. Inducible activation of Ras and Raf in adult epidermis.
Tarutani M; Cai T; Dajee M; Khavari PA
Cancer Res; 2003 Jan; 63(2):319-23. PubMed ID: 12543782
[TBL] [Abstract][Full Text] [Related]
10. A proline-rich sequence unique to MEK1 and MEK2 is required for raf binding and regulates MEK function.
Catling AD; Schaeffer HJ; Reuter CW; Reddy GR; Weber MJ
Mol Cell Biol; 1995 Oct; 15(10):5214-25. PubMed ID: 7565670
[TBL] [Abstract][Full Text] [Related]
11. Cloning and characterization of two distinct human extracellular signal-regulated kinase activator kinases, MEK1 and MEK2.
Zheng CF; Guan KL
J Biol Chem; 1993 May; 268(15):11435-9. PubMed ID: 8388392
[TBL] [Abstract][Full Text] [Related]
12. Inducible expression of a mutant form of MEK1 in Swiss 3T3 cells.
Syu LJ; Guan KL; Saltiel AR
J Cell Biochem; 1997 Dec; 67(3):367-77. PubMed ID: 9361191
[TBL] [Abstract][Full Text] [Related]
13. Mitogen-activated protein kinase (MAPK)-docking sites in MAPK kinases function as tethers that are crucial for MAPK regulation in vivo.
Grewal S; Molina DM; Bardwell L
Cell Signal; 2006 Jan; 18(1):123-34. PubMed ID: 15979847
[TBL] [Abstract][Full Text] [Related]
14. p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression.
Westermarck J; Li SP; Kallunki T; Han J; Kähäri VM
Mol Cell Biol; 2001 Apr; 21(7):2373-83. PubMed ID: 11259586
[TBL] [Abstract][Full Text] [Related]
15. A role for mitogen-activated protein kinase activation by integrins in the pathogenesis of psoriasis.
Haase I; Hobbs RM; Romero MR; Broad S; Watt FM
J Clin Invest; 2001 Aug; 108(4):527-36. PubMed ID: 11518726
[TBL] [Abstract][Full Text] [Related]
16. MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells.
Whitehurst CE; Geppert TD
J Immunol; 1996 Feb; 156(3):1020-9. PubMed ID: 8557975
[TBL] [Abstract][Full Text] [Related]
17. Transfection of constitutively active mitogen-activated protein/extracellular signal-regulated kinase kinase confers tumorigenic and metastatic potentials to NIH3T3 cells.
Welch DR; Sakamaki T; Pioquinto R; Leonard TO; Goldberg SF; Hon Q; Erikson RL; Rieber M; Rieber MS; Hicks DJ; Bonventre JV; Alessandrini A
Cancer Res; 2000 Mar; 60(6):1552-6. PubMed ID: 10749122
[TBL] [Abstract][Full Text] [Related]
18. PAK1 primes MEK1 for phosphorylation by Raf-1 kinase during cross-cascade activation of the ERK pathway.
Coles LC; Shaw PE
Oncogene; 2002 Mar; 21(14):2236-44. PubMed ID: 11948406
[TBL] [Abstract][Full Text] [Related]
19. Kinase suppressor of ras is necessary for tumor necrosis factor alpha activation of extracellular signal-regulated kinase/mitogen-activated protein kinase in intestinal epithelial cells.
Yan F; Polk DB
Cancer Res; 2001 Feb; 61(3):963-9. PubMed ID: 11221891
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
Wen-Sheng W
Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]